Obesity and long-term clinical and economic outcomes in coronary artery disease patients

Obesity Research

Volumn 10, Issue 2, 2002, Pages 83-91

  Eisenstein, Eric L ^a   Shaw, Linda K ^a   Nelson, Charlotte L ^a   Anstrom, Kevin J ^a   Hakim, Zafar ^b   Mark, Daniel B ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b Roche Global Pharmacoeconomic Res   (United States)

Author keywords

Acute coronary syndromes; Body mass index; Coronary artery disease; Economic analysis

Indexed keywords

AGE; AGED; ARTICLE; BODY MASS; CORONARY ARTERY DISEASE; COST OF ILLNESS; ECONOMICS; FEMALE; HEALTH CARE COST; HEART CATHETERIZATION; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MORTALITY; OBESITY; SEX DIFFERENCE; STATISTICS; SURVIVAL RATE; TREATMENT OUTCOME;

AGE FACTORS; AGED; BODY MASS INDEX; CORONARY DISEASE; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HEART CATHETERIZATION; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OBESITY; SEX FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036479905     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2002.14     Document Type: Article

References (36)

1. American Heart Association. 2001 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association; 2001.
2. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960 to 1991. J Am Med Assoc. 1994;272:205-11.
3. Rosenbaum M, Leibel RL, Hirsch J. Medical progress: obesity. N Engl J Med. 1997;337:396-407.
4. Wolf AM. What is the economic case for treating obesity? Obes Res. 1998;6:2S-7S.
5. Wolf AM, Corditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res. 1998;6:97-106.
6. Kortt MA, Langley PC, Cox ER. A review of cost-of-illness studies in obesity. Clin Ther. 1998;20:772-9.
7. Reavin GM. Banting lecture: role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
8. Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chron Dis. 1979;32:563-76.
9. Garrison RJ, Castelli WP. Weight and 30-year mortality of men in the Framingham Study. Ann Intern Med. 1985;103: 1006-9.
10. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995;333:677-85.
11. Rabkin MT, Mathewson FA, Hsu PH. Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. Am J Cardiol. 1977;39:452-8.
12. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary artery disease. Circulation. 1998;97:2099-100.
13. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993;119:655-60.
14. Feinleib M. Epidemiology of obesity in relation to health hazards. Ann Intern Med. 1985;103:1019-24.
15. Thompson D, Edelsberg J, Colditz GA, Bird AP, Oster G. Lifetime health and economic consequences of obesity. Arch Intern Med. 1999;159:2177-83.
16. Harris PJ, Harrell FE Jr, Lee KL, Behar VS, Rosati RA. Survival in medically treated coronary artery disease. Circulation. 1979;60:1259-69.
17. Califf RM, Harrell FE Jr, Lee KL, et al. The evolution of medical and surgical therapy for coronary artery disease: a 15-year perspective. J Am Med Assoc. 1989;261:2077-86.
18. National Heart, Lung, and Blood Institute Obesity Education Initiative Expert Panel. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Rockville, MD: National Heart, Lung, and Blood Institute; 1998.
19. Rosati RA, McNeer JF, Starmer CF, Mittler BS, Morris JJ Jr, Wallace AG. A new information system for medical practice. Arch Intern Med. 1975;135:1017-24.
20. Fortin DF, Califf RM, Pryor DB, Mark DB. The way of the future redux. Am J Cardiol. 1995;76:1177-82.
21. Mark DB, Nelson CL, Califf RM, et al. The continuing evolution of therapy for coronary artery disease: initial results from the era of coronary angioplasty. Circulation. 1994;89: 2015-25.
22. Mark DB, Granger CB, Ellis SG, et al. Costs of direct angioplasty versus thrombolysis for acute myocardial infarction: results from the GUSTO II randomized trial. Circulation. 1996;94:168 (abstr).
23. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
24. Bang H, Tsiatis AA. Estimating medical costs with censored data. Biometrika. 2000;87:329-43.
25. Franzosi MG, Santoro E, De Vita C, et al. Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza hell'Infarto Miocardico (GISSI-I) study. Circulation. 1998;98:2659-65.
26. Eisenstein EL, Shaw LK, Nelson CL, Hakim Z, Hasselblad V, Mark DB. Assessing the clinical and economic burden of coronary artery disease: 1986-1998. Med Care. 2001;39:824-35.
27. Barbash GI, Reiner J, White HD, et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. J Am Coll Cardiol. 1995;26:1222-9.
28. Patel V, Topol EJ. Lessons from the GUSTO trials. In: Topol EJ, ed. Acute Coronary Syndromes. New York, NY: Marcel Dekker; 2001, pp. 725-64.
29. Gottlieb SH, Fallavollita J, McDermott MF, Brown ML, Eberly S, Moss AJ. Cigarette smoking and age at onset of a first non-fatal myocardial infarction. Coron Artery Dis. 1994; 5:687-94.
30. Andrikopoulos GK, Richter DJ, Dilaveris PE, et al. Inhospital mortality of habitual cigarette smokers after acute myocardial infarction: the "smoker's paradox" in a countrywide study. Eur Heart J. 2001;22:776-84.
31. Goldstein MG, Niaura R. Smoking. In: Topol EJ, ed. Comprehensive Cardiovascular Medicine. Philadelphia, PA: Lippincott-Raven; 1998, pp. 159-84.
32. Stone NJ. Diet, nutritional issues, and obesity. In: Topol EJ, ed. Comprehensive Cardiovascular Medicine. Philadelphia, PA: Lippincott-Raven; 1998, pp. 45-70.
33. Frank S, Colliver JA, Frank A. The electrocardiogram in obesity: statistical analysis of 1029 patients. J Am Coll Cardiol 1986;7:295-9.
34. Suwaidi JA, Higano ST, Holmes D Jr, Lennon R, Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol. 2001;37:1523-8.
35. Quesenberry CP, Caan B, Jacobson A. Obesity, health service use, and health care costs among members of a health maintenance organization. Arch Intern Med. 1998;159:2177-83.
36. Thompson D, Brown JB, Nichols GA, Elmer PJ, Oster G. Body mass index and future healthcare costs: a retrospective cohort study. Obes Res. 2001;9:210-8.